Search Results
Nov 03, 2025, 07:00 ET Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress
NCT04562389) completed enrollment with 353 patients in early September 2025. SENTRY is evaluating 60 mg once-weekly selinexor in combination with ruxolitinib compared to ruxolitinib plus placebo. The preliminary baseline characteristics for patients enrolled
More news about: Karyopharm Therapeutics Inc.
Nov 01, 2025, 08:00 ET Semaglutida entra para o "hall da fama" da revista Time como uma das melhores invenções dos últimos 25 anos
conta atualmente com cerca de 2.500 funcionários e está presente com escritório corporativo em São Paulo (SP) e unidade de produção em Montes Claros (MG). Para mais informações, visite www.novonordisk.com.br e siga nossos perfis oficiais nas redes
More news about: NOVO NORDISK
Oct 31, 2025, 13:04 ET BIMZELX® (bimekizumab-bkzx) Data in Hidradenitis Suppurativa Showed Improvements in Pain and Resolution of Draining Tunnels Sustained to Three Years
group, n=556) at Week 48. Only patients who entered the third year are included.2-5 The approved dosing regimen is BIMZELX 320mg Q2W to Week 16 and then 320mg Q4W thereafter.1 Results included patients receiving both Q2W and Q4W after Week 48. Per protocol, all patients who continued
More news about: UCB
Oct 31, 2025, 09:00 ET Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.
excessive excitation of iPSC motor neurons from ALS patients. Moreover, in the SOD-1 ALS transgenic mouse model, daily oral administration of CB03-154 (10 mg/kg) can effectively prolong the survival time, delay the onset, improve motor ability, alleviate neuronal damage, and slow down the rate of muscle atrophy.
More news about: Shanghai Zhimeng Biopharma Inc.
Oct 31, 2025, 08:00 ET Mallinckrodt to Present Data on Terlipressin at the 2025 American Association for the Study of Liver Diseases (AASLD) Annual Meeting
hepatorenal syndrome with rapid reduction in kidney function. Patients with a serum creatinine >5 mg/dL are unlikely to experience benefit. IMPORTANT SAFETY INFORMATION
More news about: Mallinckrodt plc
Oct 31, 2025, 08:00 ET Servier's VORANIGO® (vorasidenib) Receives Prestigious 2025 Prix Galien USA Award
VORANIGO IMPORTANT SAFETY INFORMATION What is VORANIGO? VORANIGO (40 mg tablets) is a prescription medicine used to treat adults and children 12 years of age and older with certain types of brain tumors called astrocytoma
More news about: Servier Pharmaceuticals
Oct 31, 2025, 07:49 ET AbbVie Reports Third-Quarter 2025 Financial Results
(AA). In the study, Rinvoq achieved the primary endpoint, demonstrating that 45.2% and 55.0% of patients with severe AA treated with Rinvoq 15 mg and 30 mg, respectively, reached 80% or more scalp hair coverage at week 24 as defined by the severity of alopecia tool (SALT) score ≤ 20. Key secondary endpoints,
More news about: AbbVie
Oct 30, 2025, 15:37 ET MG Properties Acquires Dockside Apartments in Kent, Washington for $95.6 Million
www.mgproperties.com. ABOUT MG PROPERTIES MG Properties is a privately owned, fully integrated real estate company specializing in the investment, redevelopment, and management of multi-family assets. Headquartered in San Diego, California, MG Properties was founded in 1992
More news about: MG Properties
Oct 30, 2025, 08:00 ET Mallinckrodt to Present Data on Terlipressin in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at Kidney Week 2025
treated with terlipressin.1 Paracentesis was recorded from treatment initiation up to 14 days or until ≥1 serum creatinine (SCr) value ≤1.5 mg/dL while on treatment ≤24 hours after the last dose of study drug was recorded.1 Poster #SA-PO1188:
More news about: Mallinckrodt plc
Oct 30, 2025, 07:01 ET Monster Energy Unleashes New Full Sugar FLAVORS Line
Electric Blue delivers a "shockingly smooth" blue raspberry hit with 160mg of caffeine per 16oz can. Reminiscent of a blue raspberry popsicle, this true classic offers a sweet and tangy flavor that combines the boldness of berries
More news about: Monster Energy
Oct 30, 2025, 07:00 ET Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update
patients treated with placebo and BRINSUPRI 10 mg and 25 mg, respectively. Skin Cancers In ASPEN, the incidence of skin cancers among patients treated with BRINSUPRI 10 mg and 25 mg was 0.5% and 1.9%, respectively, compared to
More news about: Insmed Incorporated
Oct 30, 2025, 06:43 ET Breckenridge announces launch of Everolimus Tablets, 1mg, generic version of Zortress®
strengths of Everolimus Tablets in both bottles and blister card configurations. Breckenridge previously launched its Everolimus Tablets in 0.25mg, 0.5mg, and 0.75mg strengths, with blisters launched in July 2021 and bottles launched in June 2023. We continue to focus on the development of
More news about: Breckenridge Pharmaceutical, Inc.
Oct 30, 2025, 03:28 ET U.S. FDA grants interchangeability designation to Celltrion's denosumab biosimilars, STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo)
STOBOCLO and OSENVELT were introduced in the U.S. market in July 2025. STOBOCLO is currently available in 60 mg/mL injection and OSENVELT is offered in 120 mg/1.7 mL (70 mg/mL) injection. According to recent FDA draft guidance, biosimilar applicants can request an interchangeability
More news about: Celltrion
Oct 29, 2025, 14:30 ET Accelerating Radiopharmaceutical Therapy with Translational Tools, Upcoming Webinar Hosted by Xtalks
dosimetry and efficacy studies that inform smarter clinical decisions. The speakers will share how a glioblastoma case study ([¹⁷⁷Lu]FAP-2886 in the U87MG model) demonstrates target validation, efficacy readouts and multi-target expression profiling.
More news about: Xtalks
Oct 29, 2025, 14:16 ET Cycling Frog THC Seltzers Now Available on Gopuff in Tennessee, Wisconsin, and Florida
Black Currant, and Ruby Grapefruit — all made with clean ingredients, balanced cannabinoid ratios, and crafted for good times without the hangover. Each 5mg THC seltzer offers a consistent, uplifting experience designed for social settings, weekend gatherings, and moments of relaxation without the alcohol.
More news about: Cycling Frog
Oct 29, 2025, 12:00 ET UCB opens applications for 2026 UCB Myasthenia Gravis Scholarship™
announced the opening of applications for the second annual UCB U.S. Myasthenia Gravis Scholarship™, supporting individuals impacted by myasthenia gravis (MG) including patients, caregivers, and family members who are pursuing further education. To learn more the UCB Myasthenia Gravis Scholarship, or to apply
More news about: UCB
Oct 29, 2025, 10:48 ET JSPR INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In JSPR To Contact Him Directly To Discuss Their Options
2025, Jasper issued a press release reporting updated data from the BEACON Study. The press release stated that "[r]esults from the 240mg Q8W and the 240mg followed by 180mg Q8W dose cohorts appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed
More news about: Faruqi & Faruqi, LLP
Oct 29, 2025, 08:11 ET AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ®) in Adults and Adolescents with Vitiligo
tablet. Take RINVOQ exactly as your HCP tells you to use it. RINVOQ is available in 15 mg, 30 mg, and 45 mg extended-release tablets. RINVOQ LQ is taken twice a day with or without food. RINVOQ LQ is available in a 1 mg/mL oral solution. RINVOQ LQ is not the same as RINVOQ tablets. Do not switch between
More news about: AbbVie
Oct 29, 2025, 08:05 ET Johnson & Johnson announces first head-to-head study comparing IMAAVY™ with an alternative FcRn blocker in generalized myasthenia gravis (gMG) at AANEM Annual Meeting
percent of individuals diagnosed with MG are women, and about one in five of those women are of child-bearing potential.9,10,11 Approximately 10 to 15% of new cases of MG are diagnosed in pediatric patients 12-17 years of age.12,13,14 Among juvenile MG patients, girls are affected more
More news about: Johnson & Johnson
Oct 29, 2025, 07:00 ET LillyDirect and Walmart Pharmacy launch first retail pick-up option with direct-to-consumer pricing for Zepbound
$349 per month for the 2.5 mg recommended starting dose $499 per month for all other doses (5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg) To access the $499 monthly price for doses higher than 5 mg, patients must meet the requirements for the Zepbound Self
More news about: Eli Lilly and Company
Oct 29, 2025, 07:00 ET UCB to unveil new data for RYSTIGGO® (rozanolixizumab-noli) and ZILBRYSQ®(zilucoplan) for gMG at the 2025 AANEM Annual Meeting and MGFA Scientific Session
RYSTIGGO® (rozanolixizumab-noli)1 and the impact of ZILBRYSQ® (zilucoplan) on Myasthenia Gravis Quality of Life 15-revised (MG-QoL15r) items.2 ATLANTA, Oct.
More news about: UCB
Oct 29, 2025, 06:00 ET Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System
screening, open label (12-week period, participants will receive a single daily 10 mg dose of ampreloxetine), randomized withdrawal (eight-week period, double-blind, placebo-controlled, participants will receive a single daily 10 mg dose of placebo or ampreloxetine), and a long-term treatment extension. Secondary
More news about: Theravance Biopharma, Inc.
Oct 28, 2025, 16:01 ET Neurocrine Biosciences Reports Third Quarter 2025 Financial Results
statistically significant and clinically meaningful improvement in depression severity at Day 28 and Day 56 with once-daily oral administration of 1 mg osavampator. In recognition of the data presentation, the Company was honored with the 2025 Poster Award at the 38th annual Psych Congress
More news about: Neurocrine Biosciences, Inc.
Oct 28, 2025, 11:16 ET Children of Fallen Patriots Announces Major General Rich Johnson as CEO
While Fallen Patriots' core values remain consistent, MG Johnson brings proven leadership, deep commitment, and perspective that will build on the Fallen Patriots' legacy and accelerate its impact. As a mission-driven senior executive, MG Johnson offers more than 38 years of leadership experience
More news about: Children of Fallen Patriots Foundation
Oct 28, 2025, 10:07 ET Harbour BioMed Launches First Fully Human Generative AI HCAb Model to Accelerate Next-Generation Biologics Discovery
specificity. These AI-designed binders demonstrated outstanding developability profiles, with an average yield exceeding 700 mg/L. Multiple candidate sequences showed nanomolar-level binding affinity while maintaining binding activity against relevant targets in both humans and
More news about: Harbour BioMed